Tscan Therapeutics Inc (TCRX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.01B
EV to revenue ratio (TTM)
0.50
EV to ebitda
0.39
Financial Performance
Revenue (TTM)
$0.01B
Gross profit (TTM)
-$0.09B
EBITDA
-$0.12B
Profitability
Operating margin (TTM)
-2,901.00%
Profit margin
<0.01%
Return on assets (TTM)
-31.50%
Return on equity (TTM)
-95.80%
Per Share Metrics
Revenue per share (TTM)
$0.11
EPS
-$0.91
Diluted EPS (TTM)
-$0.91
Book value
$1.02
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
1.73
Price to book ratio (TTM)
0.19
Growth
Quarterly earnings growth (YoY)
-65.80%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
4
Hold
1
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.19